Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains
- PMID: 18082181
- DOI: 10.1016/j.jmb.2007.11.051
Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains
Abstract
Previous studies indicate that binding of alpha-synuclein to membranes is critical for its physiological function and the development of Parkinson's disease (PD). Here, we have investigated the association of fluorescence-labeled alpha-synuclein variants with different types of giant unilamellar vesicles using confocal microscopy. We found that alpha-synuclein binds with high affinity to anionic phospholipids, when they are embedded in a liquid-disordered as opposed to a liquid-ordered environment. This indicates that not only electrostatic forces but also lipid packing and hydrophobic interactions are critical for the association of alpha-synuclein with membranes in vitro. When compared to wild-type alpha-synuclein, the disease-causing alpha-synuclein variant A30P bound less efficiently to anionic phospholipids, while the variant E46K showed enhanced binding. This suggests that the natural association of alpha-synuclein with membranes is altered in the inherited forms of Parkinson's disease.
Similar articles
-
Helical alpha-synuclein forms highly conductive ion channels.Biochemistry. 2007 Dec 18;46(50):14369-79. doi: 10.1021/bi701275p. Epub 2007 Nov 22. Biochemistry. 2007. PMID: 18031063
-
Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.Biochemistry. 2006 Mar 14;45(10):3386-95. doi: 10.1021/bi052344d. Biochemistry. 2006. PMID: 16519533
-
Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.Biochemistry. 2008 Feb 5;47(5):1425-34. doi: 10.1021/bi701522m. Epub 2008 Jan 8. Biochemistry. 2008. PMID: 18179253
-
Controlling the mass action of alpha-synuclein in Parkinson's disease.J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
-
Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.Biochem Soc Trans. 2005 Nov;33(Pt 5):1106-10. doi: 10.1042/BST20051106. Biochem Soc Trans. 2005. PMID: 16246056 Review.
Cited by
-
"Janus-Faced" α-Synuclein: Role in Parkinson's Disease.Front Cell Dev Biol. 2021 May 28;9:673395. doi: 10.3389/fcell.2021.673395. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34124057 Free PMC article. Review.
-
Evidence for alterations in lipid profiles and biophysical properties of lipid rafts from spinal cord in sporadic amyotrophic lateral sclerosis.J Mol Med (Berl). 2024 Mar;102(3):391-402. doi: 10.1007/s00109-024-02419-7. Epub 2024 Jan 29. J Mol Med (Berl). 2024. PMID: 38285093 Free PMC article.
-
Membrane Remodeling by Arc/Arg3.1.Front Mol Biosci. 2021 Mar 8;8:630625. doi: 10.3389/fmolb.2021.630625. eCollection 2021. Front Mol Biosci. 2021. PMID: 33763452 Free PMC article.
-
Stability of protein-decorated mixed lipid membranes: The interplay of lipid-lipid, lipid-protein, and protein-protein interactions.J Chem Phys. 2009 Jan 28;130(4):045102. doi: 10.1063/1.3063117. J Chem Phys. 2009. PMID: 19191415 Free PMC article.
-
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis.Acta Neuropathol Commun. 2020 May 6;8(1):63. doi: 10.1186/s40478-020-00935-4. Acta Neuropathol Commun. 2020. PMID: 32375870 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources